Showing results (1-10 of 176) with videos related to
Sort By:
Pageof 18
Nederlands Tijdschrift Voor Geneeskunde|April 13, 2012
[Immunotherapy for type 1 diabetes mellitus (DM1)]Cornelis R van der Torren, Bart O RoepDiabetologia|October 23, 2015
Innate and adaptive immunity to human beta cell lines: implications for beta cell therapyCornelis R van der Torren, Arnaud Zaldumbide, Dave L Roelen, et al.Diabetologia|October 28, 2016
Immunogenicity of human embryonic stem cell-derived beta cellsCornelis R van der Torren, Arnaud Zaldumbide, Gaby Duinkerken, et al.Plos One|January 12, 2016
Serum Cytokines as Biomarkers in Islet Cell Transplantation for Type 1 DiabetesCornelis R van der Torren, Annemarie A Verrijn Stuart, DaHae Lee, et al.Transplantation|August 6, 2013
Pretransplantation GAD-autoantibody status to guide prophylactic antibody induction therapy in simultaneous pancreas and kidney transplantationJan Ringers, Cornelis R van der Torren, Pieter van de Linde, et al.Current Medicinal Chemistry|July 23, 2003
Molecular mimicry in autoimmune neurological disease after viral infectionBart O RoepFrontiers in Immunology|February 3, 2023
The need and benefit of immune monitoring to define patient and disease heterogeneity, mechanisms of therapeutic action and efficacy of intervention therapy for precision medicine in type 1 diabetesBart O RoepSpringer Seminars in Immunopathology|December 28, 2002
Autoreactive T cells in endocrine/organ-specific autoimmunity: why has progress been so slow?Bart O RoepAnnals of the New York Academy of Sciences|March 23, 2007
Are insights gained from NOD mice sufficient to guide clinical translation? Another inconvenient truthBart O RoepNovartis Foundation Symposium|February 11, 2009
Immune markers of disease and therapeutic intervention in type 1 diabetesBart O RoepPageof 18